Bloomage Biotechnology

Bloomage Biotechnology Corporation Limited (formerly Bloomage Freda Biopharm) was founded by the Bloomage International Investment Group. It has gained global recognition as a manufacturer of bioactive materials. During the 1990s, it became the pioneering company in China to devise the fermentation process for producing sodium hyaluronate. It has also developed approximately 200 variations of hyaluronic acid utilized in the pharmaceutical, medical devices, cosmetics, and functional foods sectors. Functioning as a raw material business division, Bloomage Biotech delivers inventive solutions and technical assistance to its collaborators. Meanwhile, in 2000, Bloomage Biotech (previously Bloomage Freda Biopharm Co., Ltd.) embarked on its journey as a producer of hyaluronic acid through microbial fermentation. Over two decades later, Bloomage Biotech has positioned itself as a leading global biotechnology and biomaterial enterprise specializing in the industrialization of hyaluronic acid. Bloomage Biotech is committed to enriching people’s lifestyles by establishing healthier experiences

Sites

BLOOMAGE BIOTECH CORP. LTD

Audited

Country

People's Republic of China

City

Ji Nan Shi

Address

Tian Chen Lu, Li Xia Qu, Ji Nan Shi, Shan Dong Sheng, China

Bloomage Biotech Co., Ltd.

Audited

Country

People's Republic of China

City

Jinan, Shandong

Country

People's Republic of China

City

Jinan